loading
전일 마감가:
$3.02
열려 있는:
$3.02
하루 거래량:
1.39M
Relative Volume:
1.12
시가총액:
$429.27M
수익:
$288.95M
순이익/손실:
$-119.03M
주가수익비율:
-3.2871
EPS:
-0.9005
순현금흐름:
$60.67M
1주 성능:
-5.73%
1개월 성능:
-26.37%
6개월 성능:
+7.64%
1년 성능:
-28.16%
1일 변동 폭
Value
$2.915
$3.09
1주일 범위
Value
$2.915
$3.21
52주 변동 폭
Value
$1.665
$4.40

마라바이 라이프 Stock (MRVI) Company Profile

Name
명칭
Maravai Lifesciences Holdings Inc
Name
전화
(858) 546-0004
Name
주소
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Name
직원
550
Name
트위터
Name
다음 수익 날짜
2025-03-18
Name
최신 SEC 제출 서류
Name
MRVI's Discussions on Twitter

Compare MRVI vs VRTX, REGN, ARGX, ALNY, ONC

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
MRVI
Maravai Lifesciences Holdings Inc
2.96 437.97M 288.95M -119.03M 60.67M -0.9005
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
491.47 117.98B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
803.17 82.85B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
821.96 51.58B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
314.40 40.75B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ONC
Beone Medicines Ltd Adr
346.07 38.33B 4.98B 69.60M 525.67M 0.5198

마라바이 라이프 Stock (MRVI) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-02-26 다운그레이드 Robert W. Baird Outperform → Neutral
2024-12-19 개시 Guggenheim Neutral
2024-12-05 다운그레이드 Goldman Neutral → Sell
2024-11-14 개시 Wolfe Research Peer Perform
2024-11-08 다운그레이드 William Blair Outperform → Mkt Perform
2024-08-28 개시 Wells Fargo Overweight
2024-08-13 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2024-04-10 개시 Craig Hallum Buy
2023-12-12 업그레이드 BofA Securities Neutral → Buy
2023-08-08 다운그레이드 KeyBanc Capital Markets Overweight → Sector Weight
2023-05-23 다운그레이드 Credit Suisse Outperform → Neutral
2023-05-09 다운그레이드 Goldman Buy → Neutral
2023-01-05 다운그레이드 UBS Buy → Neutral
2022-12-14 개시 Deutsche Bank Buy
2022-12-07 개시 RBC Capital Mkts Outperform
2022-11-03 다운그레이드 BofA Securities Buy → Neutral
2022-08-25 개시 Credit Suisse Outperform
2021-08-05 재개 Credit Suisse Outperform
2020-12-16 개시 KeyBanc Capital Markets Overweight
2020-12-15 개시 BofA Securities Buy
2020-12-15 개시 Credit Suisse Outperform
2020-12-15 개시 Goldman Buy
2020-12-15 개시 Jefferies Buy
2020-12-15 개시 Robert W. Baird Outperform
2020-12-15 개시 Stifel Buy
2020-12-15 개시 William Blair Outperform
2020-12-14 개시 UBS Buy
모두보기

마라바이 라이프 주식(MRVI)의 최신 뉴스

pulisher
Feb 13, 2026

Market Moves: Will REFI face regulatory challengesWeekly Investment Report & Safe Entry Momentum Stock Tips - baoquankhu1.vn

Feb 13, 2026
pulisher
Feb 12, 2026

Options Flow: Will Cohen Company Inc face regulatory challengesQuarterly Trade Review & Smart Investment Allocation Tips - baoquankhu1.vn

Feb 12, 2026
pulisher
Feb 12, 2026

Gainers Report: Is Maravai LifeSciences Holdings Incs ROE strong enough2025 Buyback Activity & Smart Swing Trading Techniques - baoquankhu1.vn

Feb 12, 2026
pulisher
Feb 09, 2026

Maravai to Announce Q4 and Full Year 2025 Results - Intellectia AI

Feb 09, 2026
pulisher
Feb 09, 2026

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026 - Yahoo Finance

Feb 09, 2026
pulisher
Feb 09, 2026

What MACD trends signal for Maravai LifeSciences Holdings Inc. (MAR) stockQuarterly Trade Review & Reliable Breakout Stock Forecasts - mfd.ru

Feb 09, 2026
pulisher
Feb 08, 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out - ACCESS Newswire

Feb 08, 2026
pulisher
Feb 06, 2026

Growth Report: Is Tourmaline Bio Inc a speculative investmentProduct Launch & AI Powered Market Entry Strategies - baoquankhu1.vn

Feb 06, 2026
pulisher
Feb 05, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Connect - ACCESS Newswire

Feb 05, 2026
pulisher
Feb 05, 2026

Maravai LifeSciences Target of Unusually High Options Trading (NASDAQ:MRVI) - Defense World

Feb 05, 2026
pulisher
Feb 04, 2026

Volume Report: How does Maravai LifeSciences Holdings Inc score in quality rankings2025 Market WrapUp & Weekly Watchlist for Hot Stocks - baoquankhu1.vn

Feb 04, 2026
pulisher
Feb 01, 2026

Tejara Capital Ltd Has $7.04 Million Position in Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat

Feb 01, 2026
pulisher
Jan 31, 2026

Stock Analysis: Is Amylyx Pharmaceuticals Inc stock a buy or sell2025 Technical Overview & Consistent Profit Alerts - baoquankhu1.vn

Jan 31, 2026
pulisher
Jan 30, 2026

Maravai LifeSciences Holdings (MRVI): Investor Outlook Amidst A 14.54% Potential Upside - DirectorsTalk Interviews

Jan 30, 2026
pulisher
Jan 30, 2026

Market Review: What are CERo Therapeutics Holdings Inc Equity Warrants earnings expectationsJuly 2025 Price Swings & Fast Moving Market Watchlists - baoquankhu1.vn

Jan 30, 2026
pulisher
Jan 29, 2026

Aug Mood: Is Maravai LifeSciences Holdings Incs ROE strong enough2025 Valuation Update & Precise Trade Entry Recommendations - baoquankhu1.vn

Jan 29, 2026
pulisher
Jan 29, 2026

Maravai LifeSciences Holdings (NASDAQ:MRVI shareholders incur further losses as stock declines 11% this week, taking five-year losses to 90% - simplywall.st

Jan 29, 2026
pulisher
Jan 28, 2026

Maravai LifeSciences (NASDAQ:MRVI) Trading Down 8.9%What's Next? - MarketBeat

Jan 28, 2026
pulisher
Jan 27, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

Jan 27, 2026
pulisher
Jan 25, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect - accessnewswire.com

Jan 25, 2026
pulisher
Jan 24, 2026

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Maravai Lifesciences Holdings (MRVI) and CVRx (CVRX) - The Globe and Mail

Jan 24, 2026
pulisher
Jan 22, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Jan 22, 2026
pulisher
Jan 22, 2026

Maravai LifeSciences Sees Unusually Large Options Volume (NASDAQ:MRVI) - MarketBeat

Jan 22, 2026
pulisher
Jan 21, 2026

MRVI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review

Jan 21, 2026
pulisher
Jan 21, 2026

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

Jan 21, 2026
pulisher
Jan 19, 2026

Bear Alert: What is the dividend yield of Maravai LifeSciences Holdings IncRisk Management & Low Risk Growth Stock Ideas - baoquankhu1.vn

Jan 19, 2026
pulisher
Jan 19, 2026

Aug Sentiment: Does China Liberal Education Holdings Limited offer margin of safetyJuly 2025 Final Week & Consistent Growth Equity Picks - baoquankhu1.vn

Jan 19, 2026
pulisher
Jan 19, 2026

Will Maravai LifeSciences Holdings Inc. stock hit new highs in YEARPortfolio Value Summary & Advanced Technical Signal Analysis - bollywoodhelpline.com

Jan 19, 2026
pulisher
Jan 18, 2026

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - accessnewswire.com

Jan 18, 2026
pulisher
Jan 15, 2026

Maravai LifeSciences (NASDAQ:MRVI) Shares Down 5.8%Should You Sell? - MarketBeat

Jan 15, 2026
pulisher
Jan 15, 2026

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Beha - GuruFocus

Jan 15, 2026
pulisher
Jan 12, 2026

Maravai LifeSciences (NASDAQ:MRVI) & Capricor Therapeutics (NASDAQ:CAPR) Critical Review - Defense World

Jan 12, 2026
pulisher
Jan 11, 2026

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jan 11, 2026
pulisher
Jan 10, 2026

Treasury Yields: Is Maravai LifeSciences Holdings Inc stock oversold or undervaluedRisk Management & Free Growth Oriented Trading Recommendations - Bộ Nội Vụ

Jan 10, 2026
pulisher
Jan 10, 2026

Maravai LifeSciences Earnings Call: Mixed Signals - MSN

Jan 10, 2026
pulisher
Jan 10, 2026

Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q3 Loss, Misses Revenue Estimates - MSN

Jan 10, 2026
pulisher
Jan 09, 2026

Can Maravai LifeSciences Holdings Inc. stock withstand economic slowdownWatch List & AI Optimized Trading Strategy Guides - ulpravda.ru

Jan 09, 2026
pulisher
Jan 09, 2026

Maravai LifeSciences Holdings (MRVI) Stock Analysis: An Investor’s Guide to Navigating the Biotech Sector - DirectorsTalk Interviews

Jan 09, 2026
pulisher
Jan 08, 2026

Why Maravai LifeSciences Holdings Inc. stock is in analyst buy zoneJuly 2025 Sentiment & Weekly High Conviction Ideas - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

How MACOM Technology Solutions Holdings Inc. stock trades during market volatilityJuly 2025 Patterns & AI Enhanced Market Trend Forecasts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Is Maravai LifeSciences Holdings Inc. stock oversold or undervaluedTrade Entry Report & Verified Momentum Stock Ideas - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Investors Purchase High Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - MarketBeat

Jan 08, 2026
pulisher
Jan 07, 2026

Is Maravai LifeSciences Holdings Inc. stock resilient to inflationMACD Trading Signals & Rapid Portfolio Investment - Улправда

Jan 07, 2026
pulisher
Jan 07, 2026

How Maravai LifeSciences Holdings Inc. (MAR) stock gains from tech spendingStock Watchlist Updates & Free Trading Psychology Coaching - Улправда

Jan 07, 2026
pulisher
Jan 07, 2026

How buybacks impact Maravai LifeSciences Holdings Inc. stock valueEarnings Revision Updates & Identify Winning Stocks - Улправда

Jan 07, 2026
pulisher
Jan 06, 2026

Volume Summary: Can Maravai LifeSciences Holdings Inc stock withstand economic slowdownJuly 2025 Analyst Calls & Consistent Profit Alerts - Bộ Nội Vụ

Jan 06, 2026
pulisher
Jan 06, 2026

A US$75m Market Cap Boost Pleasing ToMaravai LifeSciences Holdings Insiders - simplywall.st

Jan 06, 2026
pulisher
Jan 06, 2026

Maravai LifeSciences (NASDAQ:MRVI) Nasdaq Index Life Sciences Inputs - Kalkine Media

Jan 06, 2026
pulisher
Jan 06, 2026

Net current asset value per share of Maravai Lifesciences Holdings, Inc. Class A – SWB:MAR - TradingView — Track All Markets

Jan 06, 2026
pulisher
Jan 05, 2026

Maravai LifeSciences (NASDAQ:MRVI) Trading Up 11.3%Time to Buy? - MarketBeat

Jan 05, 2026
pulisher
Jan 01, 2026

Ideas Watch: Is Maravai LifeSciences Holdings Inc. stock resilient to inflationMarket Volume Summary & Weekly Stock Performance Updates - Bộ Nội Vụ

Jan 01, 2026

마라바이 라이프 (MRVI) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$26.45
price down icon 1.12%
$45.19
price up icon 0.87%
$101.10
price up icon 0.35%
$105.87
price up icon 0.10%
$148.75
price up icon 1.77%
biotechnology ONC
$346.07
price down icon 0.10%
자본화:     |  볼륨(24시간):